[Therapeutic study VII/81 of the treatment of acute lymphoblastic leukemia in childhood]. 1986

F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
January 1987, Klinische Padiatrie,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
January 2009, Seminars in hematology,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
June 1979, Minerva pediatrica,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
January 1984, The New England journal of medicine,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
January 1999, Acta medica portuguesa,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
October 2012, [Rinsho ketsueki] The Japanese journal of clinical hematology,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
April 2013, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
December 2017, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
June 2002, Reviews in clinical and experimental hematology,
F Zintl, and W Plenert, and H Malke, and H J Blau, and W Dörffel, and P Exadaktylos, and K Hofmann, and G Korth, and W Kotte, and W Kuhnert
January 1997, The oncologist,
Copied contents to your clipboard!